Surgical Innovations Group plc (LSE:SUN) — Market Cap & Net Worth
Market Cap & Net Worth: Surgical Innovations Group plc (SUN)
Surgical Innovations Group plc (LSE:SUN) has a market capitalization of $53.91K (GBX443.09 Million) as of June 22, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31407 globally and #1198 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Surgical Innovations Group plc's stock price GBX0.48 by its total outstanding shares 932816177 (932.82 Million). Review total liabilities of Surgical Innovations Group plc to assess the company's total debt and financial obligations.
Surgical Innovations Group plc Market Cap History: 2015 to 2026
Surgical Innovations Group plc's market capitalization history from 2015 to 2026. Data shows change from $184.43K to $53.91K (-7.95% CAGR).
Index Memberships
Surgical Innovations Group plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$937.70 Million | 0.01% | #413 of 722 |
Weight: Surgical Innovations Group plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Surgical Innovations Group plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Surgical Innovations Group plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Surgical Innovations Group plc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $482.36K | $6.09 Million | $716.00K | 0.08x | 0.67x |
| 2017 | $411.43K | $8.75 Million | $626.00K | 0.05x | 0.66x |
| 2018 | $317.79K | $10.97 Million | $725.00K | 0.03x | 0.44x |
| 2019 | $232.67K | $10.73 Million | -$2.62 Million | 0.02x | N/A |
| 2020 | $187.27K | $6.33 Million | -$3.28 Million | 0.03x | N/A |
| 2021 | $266.72K | $9.13 Million | -$456.00K | 0.03x | N/A |
| 2022 | $181.59K | $11.34 Million | $264.00K | 0.02x | 0.69x |
| 2023 | $68.10K | $12.01 Million | -$509.00K | 0.01x | N/A |
| 2024 | $62.42K | $11.95 Million | -$1.94 Million | 0.01x | N/A |
| 2025 | $51.07K | $11.60 Million | -$895.00K | 0.00x | N/A |
Competitor Companies of SUN by Market Capitalization
Companies near Surgical Innovations Group plc in the global market cap rankings as of June 22, 2026.
Key companies related to Surgical Innovations Group plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Surgical Innovations Group plc Historical Marketcap From 2015 to 2026
Between 2015 and today, Surgical Innovations Group plc's market cap moved from $184.43K to $ 53.91K, with a yearly change of -7.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX53.91K | +5.56% |
| 2025 | GBX51.07K | -18.18% |
| 2024 | GBX62.42K | -8.33% |
| 2023 | GBX68.10K | -62.50% |
| 2022 | GBX181.59K | -31.91% |
| 2021 | GBX266.72K | +42.42% |
| 2020 | GBX187.27K | -19.51% |
| 2019 | GBX232.67K | -26.79% |
| 2018 | GBX317.79K | -22.76% |
| 2017 | GBX411.43K | -14.71% |
| 2016 | GBX482.36K | +161.54% |
| 2015 | GBX184.43K | -- |
End of Day Market Cap According to Different Sources
On Jun 21st, 2026 the market cap of Surgical Innovations Group plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $53.91K USD |
| MoneyControl | $53.91K USD |
| MarketWatch | $53.91K USD |
| marketcap.company | $53.91K USD |
| Reuters | $53.91K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Surgical Innovations Group plc
Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. The company operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. It o… Read more